Departement of Medical Oncology, National Institute of Oncology, Rabat, Morocco.
World J Surg Oncol. 2010 Nov 14;8:98. doi: 10.1186/1477-7819-8-98.
Transitional cell carcinoma (TCC) of the ovary is a rare, recently recognized, subtype of ovarian surface epithelial cancer.
A 69-year-old postmenopausal woman presented with a 2-year history of progressive enlargement of an abdominal mass. Abdominal computed tomography showed a pelvic mass. CA-125 was normal. A staging operation with total abdominal hysterectomy, bilateral salpingo-oophorectomy, infracolic omentectomy and pelvic lymph node dissection was performed. After surgery, the pathologic report of the right ovarian tumour was TCC, grade 3, stage IC. The patient underwent 3 cycles of chemotherapy: carboplatin and paclitaxel. She is regularly followed up and has been disease free for 10 months
Transitional cell carcinoma (TCC) of the ovary is a rare subtype of epithelial ovarian cancer. Surgical resection is the primary therapeutic approach, and patient outcomes after chemotherapy are better than for other types of ovarian cancers.
卵巢移行细胞癌（TCC）是一种罕见的、最近才被认识到的卵巢表面上皮性癌的亚型。
一名 69 岁绝经后妇女，因进行性增大的腹部肿块病史 2 年来就诊。腹部 CT 显示盆腔肿块。CA-125 正常。行分期手术，包括全子宫切除术、双侧附件切除术、结肠下网膜切除术和盆腔淋巴结清扫术。术后右侧卵巢肿瘤的病理报告为 TCC，G3，IC 期。患者接受了 3 个周期的化疗：卡铂和紫杉醇。她定期随访，无病生存 10 个月。
卵巢移行细胞癌（TCC）是一种罕见的上皮性卵巢癌亚型。手术切除是主要的治疗方法，化疗后患者的预后优于其他类型的卵巢癌。
